PD 1-proIL-2v (Proviva Therapeutics)

N/A

Report date: 2024/11/20 10:01:52

Base Information

Drug NamePD 1-proIL-2v (Proviva Therapeutics)
Drug Alias NamePTX-912
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-PD-1Interleukin-2 receptor subunit gamma agonists
TargetsProgrammed cell death protein 1Interleukin-2 receptor subunit gamma
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesProviva Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesProviva Therapeutics IncProviva Therapeutics (Shanghai) Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A